These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22851699)

  • 1. FHL2 binds calcineurin and represses pathological cardiac growth.
    Hojayev B; Rothermel BA; Gillette TG; Hill JA
    Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
    Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
    J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation.
    Kong Y; Shelton JM; Rothermel B; Li X; Richardson JA; Bassel-Duby R; Williams RS
    Circulation; 2001 Jun; 103(22):2731-8. PubMed ID: 11390345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
    Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
    Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
    Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
    Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.
    Stathopoulou K; Cuello F; Candasamy AJ; Kemp EM; Ehler E; Haworth RS; Avkiran M
    Biochem J; 2014 Feb; 457(3):451-61. PubMed ID: 24219103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMYA5 is a novel interaction partner of FHL2 in cardiac myocytes.
    Stathopoulou K; Schnittger J; Raabe J; Fleischer F; Mangels N; Piasecki A; Findlay J; Hartmann K; Krasemann S; Schlossarek S; Uebeler J; Wixler V; Blake DJ; Baillie GS; Carrier L; Ehler E; Cuello F
    FEBS J; 2022 Aug; 289(15):4622-4645. PubMed ID: 35176204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
    Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
    Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.
    Ni YG; Berenji K; Wang N; Oh M; Sachan N; Dey A; Cheng J; Lu G; Morris DJ; Castrillon DH; Gerard RD; Rothermel BA; Hill JA
    Circulation; 2006 Sep; 114(11):1159-68. PubMed ID: 16952979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathway.
    Finsen AV; Lunde IG; Sjaastad I; Østli EK; Lyngra M; Jarstadmarken HO; Hasic A; Nygård S; Wilcox-Adelman SA; Goetinck PF; Lyberg T; Skrbic B; Florholmen G; Tønnessen T; Louch WE; Djurovic S; Carlson CR; Christensen G
    PLoS One; 2011; 6(12):e28302. PubMed ID: 22164265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo.
    Oka T; Dai YS; Molkentin JD
    Mol Cell Biol; 2005 Aug; 25(15):6649-59. PubMed ID: 16024800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
    Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.
    Oh M; Dey A; Gerard RD; Hill JA; Rothermel BA
    J Biol Chem; 2010 May; 285(22):16623-31. PubMed ID: 20371871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
    Matulis CK; Mayo KE
    Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.
    Okamoto R; Li Y; Noma K; Hiroi Y; Liu PY; Taniguchi M; Ito M; Liao JK
    FASEB J; 2013 Apr; 27(4):1439-49. PubMed ID: 23271052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between TAK1-TAB1-TAB2 and RCAN1-calcineurin defines a signalling nodal control point.
    Liu Q; Busby JC; Molkentin JD
    Nat Cell Biol; 2009 Feb; 11(2):154-61. PubMed ID: 19136967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.